Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Knowing the right times to apply cash flow budgeting can improve liquidity and planning, especially during income volatility or irregular expenses.
23,607 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Netflix charts a high-stakes path, slowing buybacks to fund a debt-heavy growth plan and weighing a marquee deal, as ...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
Lime, the e-scooter and e-bike maker backed by Uber, aims for a 2026 IPO, even as mounting debt and a tighter funding...
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
A new wave of skepticism surrounds the Fed after a high-profile critique from a former governor. This piece explains ...
Fox is weighing a bold $23 billion plan to buy Roku and seize control of the TV operating system. If completed, the d...
Joby Aviation is transitioning from test flights to revenue growth, with 2026 guidance anchoring the stock as investo...
Costco enters a pivotal earnings season as membership revenue and e-commerce momentum drive potential upside for COST...
Visa sits at the center of a rising wave of short bets, even as it preserves a cash-generating moat. The latest data ...
As tech shares wobble, investors seek ballast. A trio of high-yield dividend ETFs is gathering attention for providin...